In sum, to date the data indicate that the administration of NK-1 receptor antagonists (Figure 1) is an excellent tool for the treatment of chronic pancreatitis induced by smoking and alcoholism, for the treatment of depression-cancer development, and for PC. This evidence concerns the gene TACR1 and cancer.